- You are viewing a Navigating Care library resource.
- Go to Library
Treatment of Recurrent Adult Acute Lymphoblastic Leukemia
For information about the treatments listed below, see the Treatment Option Overview section.
Standard treatment of recurrent adult acute lymphoblastic leukemia (ALL) may include the following:
- Combination chemotherapy followed by stem cell transplant.
- Monoclonal antibody therapy (blinatumomab or inotuzumab ozogamicin) followed by stem cell transplant.
- Low-dose radiation therapy as palliative care to relieve symptoms and improve the quality of life.
- Tyrosine kinase inhibitor therapy with dasatinib for certain patients.
Some of the treatments being studied in clinical trials for recurrent adult ALL include the following:
- A clinical trial of stem cell transplant using the patient's stem cells.
- A clinical trial of targeted therapy.
- A clinical trial of CAR T-cell therapy.
- A clinical trial of new anticancer drugs.
Use our clinical trial search to find NCI-supported cancer clinical trials that are accepting patients. You can search for trials based on the type of cancer, the age of the patient, and where the trials are being done. General information about clinical trials is also available.
Learn more:
- General Information About Adult Acute Lymphoblastic Leukemia
- Stages of Adult Acute Lymphoblastic Leukemia
- Treatment Option Overview
- Treatment of Untreated Adult Acute Lymphoblastic Leukemia
- Treatment of Adult Acute Lymphoblastic Leukemia in Remission
- Treatment of Recurrent Adult Acute Lymphoblastic Leukemia
- To Learn More About Adult Acute Lymphoblastic Leukemia
Related Articles
- General Information About Adult Acute Lymphoblastic Leukemia
- Stages of Adult Acute Lymphoblastic Leukemia
- Treatment Option Overview
- Treatment of Untreated Adult Acute Lymphoblastic Leukemia
- Treatment of Adult Acute Lymphoblastic Leukemia in Remission
- Treatment of Recurrent Adult Acute Lymphoblastic Leukemia
- To Learn More About Adult Acute Lymphoblastic Leukemia